Showing 113 of 113on this page. Filters & sort apply to loaded results; URL updates for sharing.113 of 113 on this page
Introducing Bit Bio — coding cells, the building blocks of life.
Charles River announces Bit Bio partnership, increasing drug discovery ...
Bit Bio: Cell Coding for Drug discovery and Cell Therapy – Digital ...
Synthetic biology for human health | bit.bio
bit.bio logo
BlueRock Therapeutics and bit.bio announce collaboration and option ...
bit.bio chooses Automata for automating an aspect of its production of ...
May 24 2023
Synthego and bit.bio expand strategic partnership
bit.bio | synthetic biology | precision engineered human cells
bit.bio Launches ioTracker Cells at SLAS 2025
bit.bio and Automata partnership | Automata
Synthetic Biology for Human Health | Cells Reprogrammed | bit.bio
Synthetic Biology for Human Health | Cells Reprogrammed | bit.bio | bit.bio
bit.bio launches first-of-their-kind human iPSC-derived cells for gene ...
bit.bio elevated to UK tech elite
bit.bio joins ‘Future Fifty’ as one of UK’s exciting tech companies
Consistent, Scalable Human Cells for Cell Therapies | bit.bio
bit.bio is industrialising human cell manufacturing
About us | bit.bio
IoPPN scientists collaborate with bit.bio to develop multi-cell models ...
bit.bio launches Early Access programme for ioHepatocytes, a new iPSC ...
bit.bio featured in HealthTechWorld
Our platform for Reprogramming Cell Identity | Technology | bit.bio
bit.bio launches new custom disease model cells offering, advancing ...
bit.bio's Latest Innovation, ioCRISPR-Ready Cells, Streamlines Human ...
bit.bio | Make every well in every assay count with our disease models
Transforming drug discovery and medical research | Human cell |bit.bio
bit.bio to Unveil iPSC Advancements and ioCells Toolkit at Society for ...
The next disruptive technology in medicine: human biology | bit.bio
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell ...
About bit.bio
UK Science Minister Andrew Griffith MP opens bit.bio expanded labs
bit.bio | featured on built with biology podcast
Time to shine: bit.bio sets a high bar for Life Sciences
Series C $50m boosts bit.bio in new era of cell test opportunities
Human cells constitutively expressing Cas9 | ioCells | bit.bio
Consistent and Scalable iPSC-Derived Cells | ioCells | bit.bio
bit.bio Adds Two New Human Cell Products To Accelerate Research and ...
bit.bio | Synthetic Biology | Precision Engineered Human Cells
bit.bio | Technology Networks
ioCells - Human iPSC-derived cells | bit.bio
bit.bio discovery | Our factsheet
Partner with us | bit.bio
Protocol library | ioCells | bit.bio
Studying neurodegenerative diseases without a suitable control makes it ...
bit.bio launches ioAstrocytes - Brands Review Magazine
Our platform and opti-ox™ - cell programming technology | bit.bio
bit.bio cell revolution looks to transform dementia treatments and grow ...
Reprogramming stem cells: a new innovative technology for the ...
bit.bio | team expands to further prepare for cell therapies
bit.bio launches ioAstrocytes
bit.bio Launches New Custom Disease Model Cells Offering | Technology ...
bit.bio | ioDisease Model Cell Panels | bit.bio
bit.bio + London Institute for Mathematical Sciences = progress on ...
BIT.BIO.BOT : une habitation biotechnologique conçue par ecoLogicStudio
bit.bio Expands Its Portfolio With Three New Human Cell Products for ...
ioSkeletal Myocytes | ioCells | bit.bio
Science minister opens bi.bio’s new labs as sector gets £2bn ‘Vision’ boost
Synthetic biology for human health | bit.bio | bit.bio
BIT.BIO.BOT: a prototype dwelling and collective experiment in biotech ...
bit.bio launches custom disease model cells - Drug Discovery World (DDW)
bit.bio a synthetic biology company that was spun out of Cambridge ...
#synbiobeta2024 | bit.bio
bit.bio discovery GmbH
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D. - YouTube
bit.bio unveils cell therapy pipeline, lead candidate and expanded SAB
Consistent and rapid generation of functional motor neurons from ...
Cytogenetic QC at bit.bio: How a next-generation cytogenetics platform ...
bit.bio Publishes 2025 Sustainability Report
Jobs at bit.bio
bit.bio | resource library
txTreg Cells(Bit Bio) - Drug Targets, Indications, Patents - Synapse
Custom ioDisease Model Cells | ioCells | bit.bio
iGEM Competition
bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for ...
.png%3Fwidth%3D906%26name%3DLab%2520automation%2520PS%2520(1).png&w=3840&q=75)
%2520(1).png&w=3840&q=75)
.png%3Fwidth%3D1510%26name%3DTech%2520Nets%2520online%2520symposium%2520header%2520(1).png&w=3840&q=75)
.png&w=3840&q=75)
